New drug aims to outshine standard whipworm treatment in phase II trial
NCT ID NCT07258173
First seen Dec 26, 2025 · Last updated May 22, 2026 · Updated 17 times
Summary
This study compares a single dose of the experimental drug emodepside to the standard treatment albendazole for people aged 12 and older infected with Trichuris incognita (whipworm). About 100 participants will receive one dose of either drug and be checked 14-21 days later to see if the infection is cleared. The goal is to find a more effective treatment for this parasitic infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICHURIS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.